Regeneron Wants COVID-19 Tech Patent Suit Axed
By Adam Lidgett · August 20, 2021, 6:41 PM EDT
Regeneron Pharmaceuticals Inc. wants a New York federal judge to toss a suit claiming it used poached technology in its development and testing of COVID-19 vaccines and treatments, saying the company...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login